Skip to Main Content

NISH (NITAG Support Hub) 7: Mpox : Nigeria

This Library Guide is a collection of useful documents & evidence on the efficacy, effectiveness and impact of MPox vaccines to support NITAG members and other policy makers throughout Africa with making evidence-based recommendations.

Nigeria

Cadmus, S., Akinseye, V., Besong, M., Olanipekun, T., Fadele, J., Cadmus, E., Ansumana, R., Oluwayelu, D., Odemuyiwa, S. O., & Tomori, O. (2024). Dynamics of Mpox infection in Nigeria: a systematic review and meta-analysis. Scientific Reports, 14(1), 7368. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10978922/pdf/41598_2024_Article_58147.pdf

Adetifa, I., Muyembe, J.-J., Bausch, D. G., & Heymann, D. L. (2023). Mpox neglect and the smallpox niche: a problem for Africa, a problem for the world. The lancet, 401(10390), 1822-1824. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10154003/pdf/main.pdf (NOT OA)

Anjorin, A.-A. A., Odetokun, I. A., Ashaka, O. S., Fadipe, T. O., Muhammad, A., Sogbanmu, T. O., Nyandwi, J. B., Morakinyo, O. M., Dauda, A. B., & Adetona, M. A. (2023). Critical Appraisal of Mpox (Monkeypox) in Africa using Scoping and Systematic Reviews: Epidemiology, Biochemistry, Phylogeny, Pathogenesis, Clinical Features, Diagnosis, Treatment, Biosecurity and One-Health. DOI: https://doi.org/10.21203/rs.3.rs-2684822/v1

Bragazzi, N. L., Woldegerima, W. A., Wu, J., Converti, M., Szarpak, L., Crapanzano, A., Odeh, M., Farah, R., & Khamisy-Farah, R. (2024). Epidemiological and Clinical Characteristics of Mpox in Cisgender and Transgender Women and Non-Binary Individuals Assigned to the Female Sex at Birth: A Comprehensive, Critical Global Perspective. Viruses, 16(3), 325. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10976245/pdf/viruses-16-00325.pdf

Branda, F., Romano, C., Ciccozzi, M., Giovanetti, M., Scarpa, F., Ciccozzi, A., & Maruotti, A. (2024). Mpox: An Overview of Pathogenesis, Diagnosis, and Public Health Implications. Journal of Clinical Medicine, 13(8), 2234. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11050819/pdf/jcm-13-02234.pdf

Cadmus, S., Akinseye, V., Besong, M., Olanipekun, T., Fadele, J., Cadmus, E., Ansumana, R., Oluwayelu, D., Odemuyiwa, S. O., & Tomori, O. (2024). Dynamics of Mpox infection in Nigeria: a systematic review and meta-analysis. Scientific Reports, 14(1), 7368. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10978922/pdf/41598_2024_Article_58147.pdf

Clemente, N. S., Coles, C., Paixao, E. S., Brickley, E. B., Whittaker, E., Alfven, T., Rulisa, S., Higuita, N. A., Torpiano, P., & Agravat, P. (2024). Paediatric, maternal, and congenital mpox: a systematic review and meta-analysis. The Lancet Global Health. https://www.thelancet.com/action/showPdf?pii=S2214-109X%2823%2900607-1

Djuicy, D. D., Omah, I., Parker, E., Tomkins-Tinch, C. H., Otieno, J. R., Yifomnjou, M. H. M., Essengue, L. L. M., Ayinla, A. O., Sijuwola, A. E., & Ahmed, M. I. (2024). Molecular epidemiology of recurrent zoonotic transmission of mpox virus in West Africa. medRxiv, 2024.2006. 2018.24309115.

 Flores, J., Kerna, N., Akuma, O., Ngwu, D., Carsrud, N., Holets, H., Chawla, S., Ayeni, A., Azi, C., & Okpo, N. (2024). Monkeypox (MPOX): Distinguishing Mechanisms, Epidemiology, Exposure Strata, Diagnosis, Diagnostic Tools, and Adverse Effects on the Brain, Eyes, Heart, Lungs, and Skin. EC Clinical and Medical Case Reports, 7, 01-13. DOI: 10.31080/ECCMC.2024.07.00870

 Gallo, P., Galea, N., Colucci, A., Valli, R., Schwarz, M., Belasio, E. F., d’Ari, A., Furiozzi, F., Caraglia, A., & Dalla Torre, R. (2024). Mpox: Awareness, knowledge and information channels used by individuals accessing a sexually transmitted infections Helpline. Annali di Igiene: Medicina Preventiva e di Comunita.https://annali-igiene.it/articoli/2024/online_ahead_of_print/5/Gallo%20Colucci.pdf

Gao, L., Shi, Q., Dong, X., Wang, M., Liu, Z., & Li, Z. (2023). Mpox, Caused by the MPXV of the Clade IIb lineage, goes global. Tropical Medicine and Infectious Disease, 8(2), 76. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9966881/pdf/tropicalmed-08-00076.pdf

Halwani, M. A. (2024). Endemic Cross-transmission of Mpox within Health-care Settings: A Comprehensive Review. Hail Journal of Health Sciences, 6(1), 9-18 DOI: 10.4103/hjhs.hjhs_8_24

. Iwuafor, A., Ogban, G., Ekeng, B., Owai, P., & Elem, D. Mpox Vaccination Willingness and its Socio-demographic and Psychological Determinants Among Doctors in Nigeria. virus, 1, 2.

 Klingelhöfer, D., Braun, M., Groneberg, D. A., & Brüggmann, D. (2023). Global mpox research in the light of the current outbreak: demands, drivers, and obstacles. Emerging Microbes & Infections, 12(1), 2210696. 

Laurenson-Schafer, H., Sklenovská, N., Hoxha, A., Kerr, S. M., Ndumbi, P., Fitzner, J., Almiron, M., de Sousa, L. A., Briand, S., & Cenciarelli, O. (2023). Description of the first global outbreak of mpox: an analysis of global surveillance data. The Lancet Global Health, 11(7), e1012-e1023. https://www.thelancet.com/pdfs/journals/langlo/PIIS2214-109X(23)00198-5.pdf

 Lu, J., Xing, H., Wang, C., Tang, M., Wu, C., Ye, F., Yin, L., Yang, Y., Tan, W., & Shen, L. (2023). Mpox (formerly monkeypox): pathogenesis, prevention, and treatment. Signal Transduction and Targeted Therapy, 8(1), 458. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10751291/pdf/41392_2023_Article_1675.pdf 

Mektebi, A., Elsaid, M., Yadav, T., Abdallh, F., Assker, M., Siddiq, A., Sayad, R., Saifi, M., & Farahat, R. A. (2024). Mpox vaccine acceptance among healthcare workers: a systematic review and meta-analysis. BMC public health, 24(1), 4. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10759337/pdf/12889_2023_Article_17186.pdf

Mercy, K., Tibebu, B., Fallah, M., Faria, N. R., Ndembi, N., & Tebeje, Y. K. (2024). Mpox continues to spread in Africa and threatens global health security. Nature Medicine, 30(5), 1225-1226. https://www.nature.com/articles/s41591-024-02862-6

 Musuka, G., Moyo, E., Tungwarara, N., Mhango, M., Pierre, G., Saramba, E., Iradukunda, P. G., & Dzinamarira, T. (2024). A Critical Review of Mpox Outbreaks, Risk Factors, and Prevention Efforts in Africa: Lessons Learned and Evolving Practices. IJID Regions, https://doi.org/10.1016/j.ijregi.2024.100402

 Nachega, J. B., Sam-Agudu, N. A., Ogoina, D., Mbala-Kingebeni, P., Ntoumi, F., Nakouné, E., Njouom, R., Lewis, R. F., Gandhi, M., & Rosenthal, P. J. (2024). The surge of mpox in Africa: a call for action. The Lancet Global Health. https://www.thelancet.com/action/showPdf?pii=S2214-109X%2824%2900187-6

 Ogoina, D., Damon, I., & Nakoune, E. (2023). Clinical review of human mpox. Clinical Microbiology and Infection (NOT OA)

. Okoli, G. N., Van Caeseele, P., Askin, N., & Abou-Setta, A. M. (2024). A global systematic evidence review with meta-analysis of the epidemiological characteristics of the 2022 Mpox outbreaks. Infection, 52(3), 901-921. https://link.springer.com/article/10.1007/s15010-023-02133-5

 Subissi, L., Stefanelli, P., & Rezza, G. (2024). Human mpox: global trends, molecular epidemiology and options for vaccination. Pathogens and Global Health, 118(1), 25-32. (NOT OA)

Thornhill, J., Gandhi, M., & Orkin, C. (2024). Mpox: The Reemergence of an Old Disease and Inequities. Annual Review of Medicine, 75(1), 159-175.https://doi.org/10.1146/annurev-med-080122-030714

 Tobin, E. Mpox Epidemiology and Risk Factors, Nigeria, 2022. https://www.researchgate.net 

 Ubom, A. E., Oiwoh, S. O., Ajiboye, A. D., Nyeche, S., Appiah‐Kubi, A., Sokunbi, A. E., Mbiiza, C. M., Olanrewaju, F. O., Ighorodje, E. E., & Akinkugbe, A. (2023). Mpox in pregnancy: Management, risks and challenges in Africa and lessons from the COVID‐19 pandemic. International Journal of Gynecology & Obstetrics, 163(2), 466-475.  https://doi.org/10.1002/ijgo.14810

 Yu, X., Shi, H., & Cheng, G. (2023). Mpox virus: its molecular evolution and potential impact on viral epidemiology. Viruses, 15(4), 995. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10142743/pdf/viruses-15-00995.pdf